Urology News and Research

Latest Urology News and Research

Determinants of treatment decisions in newly diagnosed prostate cancer patients

Patients with newly diagnosed prostate cancer (PCA) face the critical decision of whether to undergo treatment with curative intent (TCI, surgery or radiation) or conservative treatment on the background of a cancer where the potential for over-treatment and under-treatment is real.

23 May 2024

California pays meth users to get sober

Here in the rugged foothills of California's Sierra Nevada, the streets aren't littered with needles and dealers aren't hustling drugs on the corner.

22 May 2024

Study links higher microplastic levels in urine to endometriosis risk

A study in Ecotoxicology and Environmental Safety finds higher levels of microplastics in urine samples from endometriosis patients compared to healthy individuals.

21 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Study reveals no survival benefit from systemic therapy in very advanced solid tumors

Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published today in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer Center and Yale Cancer Center.

17 May 2024

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.

13 May 2024

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, "Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy."

10 May 2024

Researchers enhance CAR-T cells to target solid tumors

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors - an advance that could transform cancer treatment.

8 May 2024

New diagnostic and treatment approach could revolutionize bladder cancer care

A new diagnostic and treatment approach for bladder cancer will undergo a clinical trial in Queensland.

6 May 2024

What is the association between post-diagnostic plant-based dietary patterns and the risk of prostate cancer progression?

The relationship between the risk of progression of prostate cancer and plant-based diet adherence.

6 May 2024

Key transport systems fuel rapid E. coli growth in UTIs

Through a quirk of anatomy, women are especially prone to urinary tract infections, with almost half dealing with one at some point in their lives.

3 May 2024

Study links endocrine-disrupting chemical exposure to poorer sleep and vitamin D deficiency

Study in the journal Nutrients links exposure to endocrine-disrupting chemicals with vitamin D deficiency and reduced sleep duration, suggesting a compounded negative impact on health.

30 Apr 2024

Fentanyl inhalation linked to irreversible brain damage

Inhaling the synthetic opioid fentanyl may cause potentially irreversible brain damage (toxic leukoencephalopathy), warn doctors in the journal BMJ Case Reports, after treating a middle aged man found unresponsive in his hotel room after snorting the drug.

29 Apr 2024

FDA-approved surgical robots trend toward autonomy, study finds

A systematic review in npj Digital Medicine categorizes FDA-approved surgical robots by their levels of autonomy, highlighting a need for standardized definitions and greater regulatory clarity as these systems evolve towards higher autonomy.

29 Apr 2024

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine announces that it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application for ISM3412, a small molecule inhibitor of MAT2A for the potential treatment of MTAP deleted cancers designed with Insilico's generative AI platform.

25 Apr 2024

Breast cancer survivors at higher risk of developing second cancers

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England.

24 Apr 2024

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

24 Apr 2024

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

A novel diagnostic model using machine learning (ML).

24 Apr 2024

FDA approval of Anktiva heralds a new era in the treatment of BCG-unresponsive non–muscle-invasive bladder cancer

The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) for the treatment of patients with BCG-unresponsive non–muscle-invasive bladder cancer.

23 Apr 2024

Research identifies digital resources for reducing medication costs

Available online tools can help to lower out-of-pocket prescription drug costs for patients with common urologic conditions, reports a study in the May issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

23 Apr 2024

Urology News and Research

Latest Urology News and Research

Determinants of treatment decisions in newly diagnosed prostate cancer patients

California pays meth users to get sober

Study links higher microplastic levels in urine to endometriosis risk

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Study reveals no survival benefit from systemic therapy in very advanced solid tumors

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

Researchers enhance CAR-T cells to target solid tumors

New diagnostic and treatment approach could revolutionize bladder cancer care

What is the association between post-diagnostic plant-based dietary patterns and the risk of prostate cancer progression?

Key transport systems fuel rapid E. coli growth in UTIs

Study links endocrine-disrupting chemical exposure to poorer sleep and vitamin D deficiency

Fentanyl inhalation linked to irreversible brain damage

FDA-approved surgical robots trend toward autonomy, study finds

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Breast cancer survivors at higher risk of developing second cancers

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes

FDA approval of Anktiva heralds a new era in the treatment of BCG-unresponsive non–muscle-invasive bladder cancer

Research identifies digital resources for reducing medication costs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in